BioAffinity Technologies Overview
- Founded
- 2014
- Status
- Private
- Employees
- 4
- Latest Deal Type
- Debt - PPP
- Investors
- 1
BioAffinity Technologies General Information
Description
Developer of cancer diagnostic devices designed to test, detect, and treat cancer cells. The company technology analyzes a person's sputum, or phlegm, to find cancer cells that have sloughed off a lung tumor during collection of the sample, and it focuses on non-invasive, early-stage cancer screening, and diagnosis, enabling medical professionals to detect early-stage lung cancer.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- The University of Texas San Antonio
- One UTSA Circle
- San Antonio, TX 78249
- United States
+1 (210) 000-0000
BioAffinity Technologies Timeline
BioAffinity Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Debt - PPP | 15-Apr-2020 | 00.00 | Completed | |||
| 3. Angel (individual) | 15-May-2018 | 000 | 00.00 | Completed | Startup | |
| 2. Angel (individual) | 21-Jul-2017 | $4.05M | $4.2M | 0000 | Completed | Startup |
| 1. Corporate | 09-Mar-2017 | $150K | $150K | Completed | Startup |
BioAffinity Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 00 |
BioAffinity Technologies Executive Team (5)
BioAffinity Technologies Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Barry Frankel | BioAffinity Technologies | Board Member | 000 0000 |
| Gary Rubin | BioAffinity Technologies | Board Member | 000 0000 |
| Maria Zannes JD | BioAffinity Technologies | Chief Executive Officer, President & Board Member | 000 0000 |
| Myron Holubiak | Self | Board Member | 000 0000 |
| Peter Knight JD | Self | Board Member | 000 0000 |
BioAffinity Technologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBioAffinity Technologies Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| San Antonio Development Corporation | Other | Minority | 000 0000 | 000000 0 |